NYXH
NYXH
NASDAQ · Health Care

Nyxoah Sa

$3.02
+0.10 (+3.42%)
As of Apr 1, 2:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
5.71M
Net Income
-74,802,922
Gross Margin
65.7%
Profit Margin
-1,310.2%
Rev Growth
+74.4%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 65.7% 65.7% 48.0% 48.0%
Operating Margin -1,300.8% -1,170.7% 7.1% 7.9%
Profit Margin -1,310.2% -1,244.7% 6.9% 6.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.71M 3.27M 96.72M 100.81M
Gross Profit 3.75M 2.15M 46.41M 48.38M
Operating Income -74,277,995 -38,327,138 6.86M 7.92M
Net Income -74,802,922 -38,597,998 6.66M 6.06M
Gross Margin 65.7% 65.7% 48.0% 48.0%
Operating Margin -1,300.8% -1,170.7% 7.1% 7.9%
Profit Margin -1,310.2% -1,244.7% 6.9% 6.0%
Rev Growth +74.4% +74.4% -2.0% +4.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 9.75M 9.75M 61.10M 61.83M
Total Equity 48.76M 48.76M 75.28M 67.03M
D/E Ratio 0.20 0.20 0.81 0.92
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -72,570,122 -39,526,210 9.82M 10.80M
Free Cash Flow 3.28M 3.57M